Bntx stocks.

BioNTech BioNTech SE (BNTX) NASDAQ 97.16 -1.67 (-1.69%) 02:30:00 Close USD Disclaimer After-Hours 96.00 -1.16 (-1.19%) 6:27:36 GMT Overview Profile Chart News & Analysis Technical Financials...Shares of vaccine developers Moderna ( MRNA 2.74%), BioNTech SE ( BNTX -1.01%), and Novavax ( NVAX 1.27%) rallied hard on Monday, up 9.3%, 6.5%, and 13%, respectively in the day's trading. COVID ...Nov 29, 2023 · See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Feb 27, 2023 · BioNTech SE Sponsored ADR (BNTX) closed at $130.86 in the latest trading session, marking a -1.84% move from the prior day. This change lagged the S&P 500's daily gain of 0.31%.

Moreover, Bloomberg.com’s data reveals that the stock currently maintains a consensus rating of “Moderate Buy.” The majority view among investment analysts is that the target price for BNTX stands at approximately $158.69. At present, NASDAQ:BNTX opened at $113.06 on Monday, September 18th.

BioNTech SE BNTX is expected to report its fourth-quarter 2022 results later this month. BioNTech's earnings surprise history has been decent so far, having surpassed expectations in three of the ...The analyst Jessica Fye also trims her price target on BNTX to $99 from $106 per share, arguing that the sinking estimations for the company's COVID-19 vaccine business have hurt the stock "and ...

Term Box: Best BioNTech SE - ADR forecast, BNTX stock price prediction, BNTX forecast, BioNTech SE - ADR finance tips, BNTX prediction, BioNTech SE - ADR analyst report, BNTX stock price predictions 2023, BioNTech SE - ADR stock forecast, BNTX forecast tomorrow, BioNTech SE - ADR technical analysis, BNTX stock future price, BioNTech SE - ADR projections, BioNTech SE - ADR market prognosis ... (See BNTX stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a tool that unites all of TipRanks’ equity insights.BioNTech SE (ADR) share price in real-time (A2PSR2 / US09075V1026), charts and ... Frankfurt Stock Exchange · Securities · Trading · Glossary · Publications ...What this means: InvestorsObserver gives Biontech Se ADR (BNTX) an overall rank of 31, which is below average. Biontech Se ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Nov 22, 2023 · BioNTech SE (NASDAQ:BNTX) posted its quarterly earnings results on Monday, November, 6th. The company reported $0.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.59) by $1.26. The firm had revenue of $895.30 million for the quarter, compared to analysts' expectations of $850.50 million.

Shares of BioNTech ( BNTX -0.31%) were plunging 19.8% as of 11:12 a.m. EDT on Friday. The steep decline came after Pfizer ( PFE 0.50%) announced positive results from a late-stage study of its ...Coupang Inc. Last on the list, Coupang Inc. is a high-profile recent IPO stock to watch. It was the largest foreign company offering since Alibaba ( NYSE: BABA) came public in 2014. The South ...Nov 4, 2021 · Shares of BioNTech (BNTX-1.01%) were 9.1% lower as of 11:51 a.m. EDT on Thursday. The German biotech didn't report any news, so why did its stock slide? ... But stocks that share common ... The public float for BNTX is 237.70M, and currently, short sellers hold a 1.37% ratio of that floaft. The average trading volume of BNTX on November 23, 2023 was 669.58K shares. BNTX’s Market Performance. BNTX stock saw an increase of -2.73% in the past week, with a monthly gain of 2.25% and a quarterly increase of -17.72%.Average Volume (3M) 692.88K. Market Cap. $23.63B. Enterprise Value $9.96B. Total Cash (Recent Filing) €13.88B. Total Debt (Recent Filing) €212.20M. Price to Earnings (P/E) 8.5. Beta 0.70. Next Earnings.Some of the best international stocks to buy now include Alibaba Group Holding Limited (NYSE: BABA ), Nutrien Ltd. (NYSE: NTR ), and Unilever PLC (NYSE: UL ).

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Debuting at $14.24 per share, BioNTech’s stock price peaked at $112.76 per share on November 10, 2020, when news broke that that company’s vaccination candidate for the novel COVID-19 virus ...BioNTech Q3 Profit Falls, Trims FY23 Vaccine Revenue Outlook. RTTNews. Nov. 6, 2023, 08:06 AM. (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to ...

Mar 23, 2023 · Plenty of stocks have been left behind and many carry outsize yields of 6% or more—including a total of about 40 in the S&P 500 and S&P MidCap 400 indexes, according to data from S&P Dow Jones ... BioNTech (NASDAQ:BNTX) is scheduled to announce Q2 earnings results on Monday, August 7th, before market open.The consensus EPS Estimate is -$0.82 and the consensus Revenue Estimate is $797.44M ...

What is BioNTech SE (BNTX)'s stock price today? The current price of BNTX is $99.39. The 52 week high of BNTX is $188.99 and 52 week low is $88.00. When is next earnings date of BioNTech SE (BNTX)?BNTX Signals & Forecast. The Biontech Se Sponsored Adr stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.What happened. Shares of BioNTech ( BNTX 3.25%) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical ...12:00p European stocks decrease for third session 12:00p U.K. stocks decline for third day 12:00p We have $760,000 saved and $10,000 a month in Social Security and pensions.Find the latest Exxon Mobil Corporation (XOM) stock quote, history, news and other vital information to help you with your stock trading and investing.Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. BNTX - BioNTech SE ADR - Stock screener for investors and traders, financial ... BNTX stock analysts forecast roughly 16 billion euros in sales. Still, much of the outlook will depend on booster demand. Less than 10% of adults in the U.S. have gotten an updated booster shot ...

BioNTech SE ADR. An der Goldgrube 12. Mainz, Rheinland-Pfalz 55131. Phone 49 6131 908-40. Industry Biotechnology. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023. Revenue $18.19B.

BNTX: BioNTech SE - Stock Price, Quote and News - CNBC

Find the latest Better Therapeutics, Inc. (BTTX) stock quote, history, news and other vital information to help you with your stock trading and investing.CEO. Website. 2008. 5,700. Ugur Sahin. https://www.biontech.de. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is …Stock Price Forecast. The 16 analysts offering 12-month price forecasts for BioNTech SE have a median target of 124.69, with a high estimate of 264.82 and a low estimate of 98.75. The median ...BNTX Real-Time Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and ...Pfizer ( PFE -1.46%) stock was down 3.5%. Shares of BioNTech ( BNTX -2.08%) and Moderna ( MRNA -1.55%) were sinking 7.6% and 8.2%, respectively. However, Pfizer and BioNTech actually had good news ...BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary.BNTX : 98.83 (+0.89%) SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioNTech SE - BNTX PR Newswire - Tue Oct 17, 7:35PM CDT. /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE ("BioNTech" or the "Company") (NASDAQ: BNTX).BioNTech stock (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 ...Apr 20, 2023 · Nevertheless, contrarians might want to consider picking up BNTX. First, it sits among the blue-chip stocks with value based on key financial ratios. First, BNTX trades at a trailing multiple of 3 ... BioNTech SE American Depositary Share (BNTX, $99.25) entered Downtrend as Momentum indicator drops below 0 level on Nov 29, 2023. Tickeron - Stocks. Track BioNTech SE - ADR (BNTX) Stock Price, Quote, latest community messages, chart, news and other stock related information.Stock Price Forecast ... The 16 analysts offering 12-month price forecasts for BioNTech SE have a median target of 124.69, with a high estimate of 264.82 and a ...Apple Inc. Common Stock. $179.24 -0.12 -0.07%. Find the latest Earnings Report Date for BioNTech SE American Depositary Share (BNTX) at Nasdaq.com.

Dec 1, 2023 · BNTX Earnings Date and Information. BioNTech last issued its quarterly earnings results on November 6th, 2023. The reported $0.67 earnings per share for the quarter, topping the consensus estimate of ($0.59) by $1.26. The business earned $895.30 million during the quarter, compared to analyst estimates of $850.50 million. According to 13 analysts, the average rating for BNTX stock is "Buy." The 12-month stock price forecast is $146.46, which is an increase of 47.34% from the latest price.What this means: InvestorsObserver gives Biontech Se ADR (BNTX) an overall rank of 29, which is below average. Biontech Se ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 29 means that 71% of stocks appear more favorable to our system.BioNTech (BNTX) stock fell ~5% premarket Aug. 8 after the company's Q2 results missed analysts estimates, however the company reaffirmed its COVID-19 vaccine revenues outlook for...Instagram:https://instagram. guarantee trust life reviewsmichelin tires stockold violin for saletop mortgage lenders california BNTX Stock Performance on November 6, 2023: Mixed Results and Concerns for Investors. BNTX stock performances on November 6, 2023 were mixed. The stock opened at $93.34, slightly higher than the previous day’s close of $92.49. Throughout the day, the stock’s price fluctuated within a range of $93.33 to $98.34. chatham lodging trustlvhi dividend Oct 3, 2023 · BNTX’s price/forward earnings is 5.36. Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper ... Created with Sketch. Market Activity. Funds + ETFs. News + Insights. P/E & PEG Ratios. who owns survey monkey BNTX stock currently hovers slightly below $170, up 45% over the past 12 months. The stock price has declined 24.5% YTD. Shares are trading at 4.9 times forward earnings and 2.5 times trailing sales.The European Patent Office declared a contested mRNA patent owned by Moderna invalid, the office said on Tuesday, handing a win to BioNTech and its partner Pfizer in a patent dispute between the two coronavirus vaccine makers. Moderna said in a statement that it disagreed with the office's decision and would lodge an appeal.Jun 18, 2023 · BNTX Stock Assessment. Per Seeking Alpha, BioNTech's stock assessment reveals a mixed bag of results. In terms of valuation, the company is rated "A+" with forward-looking non-GAAP P/E at 20.76 ...